Literature DB >> 31804617

Effects of intradialytic exercise on cardiopulmonary capacity in chronic kidney disease: systematic review and meta-analysis of randomized clinical trials.

Francini Porcher Andrade1, Patrícia de Souza Rezende2, Tatiane de Souza Ferreira3, Gabrielle Costa Borba3, Alice Mânica Müller3, Paula Maria Eidt Rovedder4,5,6.   

Abstract

Patients with chronic kidney disease show poorer functional and cardiorespiratory capacity than healthy individuals, and these impairments result in sedentarism. The aim of this study was to conduct a systematic review and meta-analysis of randomized clinical trials on the effects of different intradialytic exercise protocols on cardiopulmonary capacity in chronic kidney disease patients. The primary outcome was peak oxygen consumption (VO2peak) and the secondary outcomes were exercise duration and ventilation in the cardiopulmonary test. The quality of the evidence was evaluated using the GRADE guidelines. Seven studies with a total of 124 participants met the inclusion criteria. Compared to the non-exercise group, the exercise group improved in mean VO2peak (MD 4.06 [IC 0.81; 7.31]). In a separate analysis according to exercise modality, aerobic exercise plus strength training performed better than aerobic exercise alone (MD 5.28 [IC 3.90; 6.66]). In the exercise group, both exercise tolerance values (MD 3.10 [IC 1.70; 4.51]) and ventilation values in the cardiopulmonary test were better than those of the control group (MD 13.10 [IC 7.12; 19.09]). Thus, intradialytic exercise protocols can improve cardiopulmonary function, exercise tolerance and ventilatory efficiency in chronic kidney disease patients.

Entities:  

Mesh:

Year:  2019        PMID: 31804617      PMCID: PMC6895108          DOI: 10.1038/s41598-019-54953-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Introduction

Patients with chronic kidney disease (CKD) have a slow, progressive and irreversible loss of renal function, causing metabolic and hydroelectrolytic imbalances. The prevalence of CKD has been increasing in recent years and, in most cases, its diagnosis is late, when renal replacement therapy is necessary through peritoneal dialysis, hemodialysis or renal transplantation[1]. CKD patients who undergo hemodialysis have poorer functional capacity, which is related to deconditioning and low tolerance for physical activity[2]. Sedentary behavior is either the cause or consequence of disease progression, and poor functional capacity is associated with increased mortality[3]. Multiple systems, including cardiovascular and respiratory function, are impaired in CKD patients on dialysis, which is induced by complications such as accumulated uremic toxins and other impurities, volume overload from fluid retention, anemia from lack of erythropoietin production and hyperparathyroidism. This is due to both hemodialysis treatment (e.g. immobility and post-dialysis fatigue) and the disease itself (uremic neuro and myopathy, anemia, cardiovascular abnormalities and electrolyte imbalance)[4-6]. Cardiovascular disease it is the main cause of morbidity and mortality in CKD, with nearly double the incidence of the general population[7]. Moreover, CKD patients with cardiovascular comorbidities have shown progressive worsening in functional capacity[8]. Respiratory complications are also common, such as interstitial pulmonary edema and restrictive spirometric patterns[5]. The cardiopulmonary exercise test (CPET) can be used to objectively determine functional capacity, which involves the pulmonary and cardiovascular systems. The peak oxygen consumption (VO2peak) value obtained in the CPET defines a person’s functional aerobic capacity and has become the gold standard for cardiopulmonary fitness[9]. Studies show that VO2peak values greater than 17.5 ml/min/Kg are predictors of survival in CKD patients, indicating that it is essential to evaluate both functional capacity and its evolution with the CPET in these patients[10]. The aim of this study was to conduct a systematic review and meta-analysis of randomized clinical trials (RCTs) on the effects of different intradialytic exercise protocols on cardiopulmonary capacity in CKD patients. Our meta-analysis expands the results by assessing the patients’ cardiopulmonary function, which often is ignored in this population.

Methods

This systematic review and meta-analysis of RCTs is registered with the International Prospective Register of Ongoing Systematic Reviews (number CRD42019119212) and followed the PRISMA Statement and the Cochrane Collaboration recommendations[11].

Eligibility criteria

The review included RCTs that involved chronic renal failure patients who underwent intradialytic exercise protocols, evaluated VO2peak (mLkg/min or liters) through cardiopulmonary testing, and featured a control group. The exclusion criteria were pediatric populations, modified drug regimens, or not using a maximal exercise test to obtain VO2peak. The primary outcome measure was VO2peak in mL/kg/min; the secondary outcome measures were exercise duration and ventilation in the cardiopulmonary test.

Search strategy

The studies were found through a systematic search of MEDLINE (accessed through PubMed), the Cochrane Central Register of Controlled Trials, and EMBASE, in addition to a manual search of the references in published studies on the subject. No publication date or language restrictions were set. The PubMed search included clinical trials, controlled clinical trials and randomized controlled trials, the Cochrane search included trials, and the EMBASE search included randomized controlled trials. Studies were eligible if they were published from the beginning of the databases until September 2018 and involved the following descriptors or synonyms: “Renal Insufficiency Chronic”, “Exercises”, “Physical Activity”, “Cardiopulmonary Exercise Tests”. The search strategy is shown in the Supplementary Information.

Study selection and data extraction

The titles and abstracts of all articles identified in the search strategy were independently evaluated by two investigators (F.P.A and T.S.F.), strictly adhering to the inclusion and exclusion criteria. For articles that did not provide enough information in the titles and abstracts, a full-text assessment was performed by the same investigators. Disagreements over inclusion were resolved by consensus among the investigators and an independent third reviewer (A.M.M). Two investigators (F.P.A. and T.S.F.) performed the data extraction independently using standardized forms. The primary extracted endpoint was peak VO2 (mL/kg/min and liters) and the secondary outcomes were cardiopulmonary test duration and peak ventilation in the cardiopulmonary test. The structured data collection form included the following study characteristics: country in which the study was conducted, date of enrolment, study design, study setting, and patient population features. The extracted numerical data included: number of patients in each study, number of patients in each group, VO2 delta value (mL/kg/min and liters), cardiopulmonary test duration delta value, delta value of peak ventilation in the cardiopulmonary test, and the exercise modality, frequency and duration.

Risk of bias assessment

The studies’ methodological quality was evaluated independently and descriptively by the same two reviewers based on Cochrane Collaboration recommendations[11]. The following items were evaluated: random sequence generation, allocation concealment, patient blinding, blinding of therapists and outcome assessors, intention-to-treat analysis, and description of losses and exclusions. If any of these items were not clearly described, they were considered not informed. Intention-to-treat analysis was defined as confirmation in the study assessment that the number of randomized participants and the number of analyzed participants were identical. Quality assessment was performed independently by two reviewers (F.P.A and T.S.F). The dates are shown in Table 1 - Supplementary Information.

Summary of evidence: GRADE criteria

The quality of the evidence was evaluated according to Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria and the Cochrane Handbook for Systematic Reviews of Interventions. For each specific outcome, the quality of evidence was based on five factors: (1) risk of bias; (2) inconsistency; (3) indirectness; (4) imprecision; and (5) publication bias. The GRADE approach resulted in four levels of quality of evidence: high, moderate, low and very low, and was performed at https://gdt.gradepro.org/app/. The data are shown in Table 2 - Supplementary Information.

Data analysis

Binary outcomes for each trial were expressed as odds ratios and 95% confidence intervals. The data from all trials were pooled as appropriate using a fixed effect model and a random effects model. Meta-analysis was performed for all outcomes in R version 3.5.0. When the standard deviation of the mean was not available, the standard error of the mean was used for the meta-analysis. The studies compared exercise training groups and control groups that did not exercise. The inconsistency test (I2) was used to assess heterogeneity among the studies; values ≥50% indicated high heterogeneity.

Results

Study selection

Figure 1 presents a flowchart of the included studies. A total of 126 studies were initially selected through the PubMed, EMBASE, and Cochrane database searches and the manual search. After removing fifteen duplicate publications, 111 studies remained, of which 39 were excluded after assessing the title and 58 after assessing the abstract. Fifteen studies remained for full text review, of which seven were included and meta-analyzed.
Figure 1

Study selection flowchart.

Study selection flowchart. Seven studies were included in the meta-analysis. Figure 1 shows the study selection flowchart. To define the intensity of the exercise protocol, the majority of the studies used the Borg Scale, which is the most appropriate instrument for CKD patients. Only two studies used the cardiopulmonary exercise test to determine the training intensity, which should be considered unreliable for this population due to the fact that beta-blocker drugs, which are widely used by these patients, interfere in the maximum heart rate. These authors did not explain how they obtained a workload of 55–60% peak power[12,13]. All studies began the exercise protocol within two hours of hemodialysis to avoid cardiovascular instability. The seven studies, published between 2008 and 2015, involved 243 patients from Brazil, France and Greece: 125 in the exercise group and 118 in the control group. The studies included a majority of males: 79 men in the exercise group and 74 in the control group, compared to 46 women in the exercise group and 44 in the control group. Table 1 shows the details of the included studies and their samples.
Table 1

Detailed characteristics of the included studies.

AuthorCountryFollow-upGroupNExercise modalityFrequencyIntensityExercise timeTime on dialysisAgeSex (male)
Groussard et al.France3 monthsE8Intradialytic cycle training3 times/week for 3 months55–60% of peak power output30 min36.6 ± 8.2*68.4 ± 3.75
(2015)C10Regular dialysis treatment41.2 ± 8.1*66.5 ± 4.67
Reboredo et al.Brazil12 weeksE12Intradialytic cycle training3 times/week for 12 weeksModified Borg scale (between 4–6)35 min3.3 ± 3.4#50.7 ± 10.75
(2011)C12Regular dialysis treatment4.8 ± 4.442.2 ± 135
Kouidi et al.Greece1 YearE24Cycling training and strength training3 times/week for 1 yearBorg scale (between 11–13)60–90 min6.1 ± 4.6#46.3 ± 11.214
(2010)C20Regular dialysis treatment6.3 ± 4.9#45.8 ± 10.912
Kouidi et al.Greece10 monthsE30Cycling training and strength training3 times/week for 10 monthsBorg scale (between 11–13)60–90 min6.3 ± 3.7#54.6 ± 8.9 518
(2009)C29Regular dialysis treatment6.2 ± 3.9#53.2 ± 6.116
Ouzouni et al.Greece10 monthsE19Cycling training, strength training and flexibility3 times/week for 10 monthsBorg scale (between 13–14)60–90 min7.7 ± 7.0#47.4 ± 15.714
(2008)C14Regular dialysis treatment8.6 ± 6.0#50,5 ± 11,713
Petraki et al.Greece7 monthsE22Cycling training, strength training and flexibility3 times/week for 10 months13 at Borg scale90 min76.32 ± 7.0*50.05 ± 3.215
(2008)C21Regular dialysis treatment10.5 ± 15.1*50.52 ± 14.417
Konstantinidou et al.Greece6 monthsE10Cycling training, strength training and flexibility3 times/week for 6 monthsApproximately 70% of HRmax60 min77 ± 66*48.3 ± 12.18
(2002)C12Regular dialysis treatment79 ± 86*50,2 ± 7,94

Legend: E: experimental group; C: control group, *time on dialysis in month; #time on dialysis in year.

Detailed characteristics of the included studies. Legend: E: experimental group; C: control group, *time on dialysis in month; #time on dialysis in year. All analyses were performed using the delta values. The heterogeneity of the VO2peak delta values (mL/kg/min) was significant (I² = 88%, r² = 16.2243, p < 0.01). However, despite the high heterogeneity, there were significant differences between the exercise and control groups in the fixed effect model (MD 2.27 [IC 1.24; 3.31]) and in the random effects model (MD 4.06 [IC 0.81; 7.31]), demonstrating that exercise during hemodialysis can benefit physical functioning (Fig. 2).
Figure 2

Difference in VO2peak mL/kg/min between pre- and post-intervention.

Difference in VO2peak mL/kg/min between pre- and post-intervention. Separate analysis according to exercise modality was also performed (aerobic exercise only or aerobic exercise plus strength training). There was a significant difference in VO2peak mL/kg/min value for aerobic exercise only in the fixed effect model (MD −1.64 [IC −3.21; −0.07]), with high and significant heterogeneity (I² = 87%, r² = 30.42, p < 0.01) (Fig. 3).
Figure 3

Difference in VO2peak mL/kg/min between intervention and control groups in patients who performed aerobic exercise alone.

Difference in VO2peak mL/kg/min between intervention and control groups in patients who performed aerobic exercise alone. Benefits to cardiopulmonary capacity were also found in studies that combined aerobic exercise and strength training, and these results were significant in both models (fixed and random effects), with similar values in fixed effect and random effects models (MD 5.28 [IC 3.90; 6.66]). The heterogeneity was not significant (I² = 0%, r² = 0, p = 0.96) (Fig. 4).
Figure 4

Difference in VO2peak mL/kg/min between intervention and control groups in patients who performed aerobic exercise and strength training.

Difference in VO2peak mL/kg/min between intervention and control groups in patients who performed aerobic exercise and strength training. There was a significant difference in cardiopulmonary test duration (in minutes) between the exercise and control groups in the fixed effect model (MD 2.74 [IC 1.90; 3.57]) and the random effects model (MD 3.10 [IC 1.70; 4.51]), with non-significant heterogeneity (I² = 56%, r² = 1.0958, p = 0.08). These results demonstrate that an exercise protocol during hemodialysis leads to greater exercise tolerance (Fig. 5).
Figure 5

Difference in cardiopulmonary test duration (in minutes) between intervention and control groups.

Difference in cardiopulmonary test duration (in minutes) between intervention and control groups. There was a significant difference in ventilation (in liters) during the cardiopulmonary test between the exercise and control groups in the fixed effect model (MD 13.54 [IC 9.26; 17.82]) and the random effects model (MD 13.10 [IC 7.12; 19.09]), with non-significant heterogeneity (I² = 42%, r² = 15.2481, p = 0.16). This result highlights the importance of intradialytic exercise for pulmonary ventilation (Fig. 6).
Figure 6

Difference in ventilation between pre- and post-intervention or between intervention and control groups.

Difference in ventilation between pre- and post-intervention or between intervention and control groups. Based on the GRADE criteria, the quality of the included studies ranged from very low to low. Of the included studies, 100% presented adequate sequence generation, 14% reported allocation concealment, 14% reported blinded assessment of outcomes and 100% described losses to follow-up and exclusions. The quality and the risk of bias assessments are provided in the Supplementary Information.

Discussion

This systematic review with meta-analysis of RCTs indicates that interventions combining intradialytic aerobic exercise and strength training effectively increase cardiopulmonary capacity and exercise tolerance. There were also significant results for ventilation during CPET (in liters), demonstrating that exercise during hemodialysis can benefit the physical functioning of these patients. The effects of intradialytic exercise were studied because this modality has better adherence among CKD patients than protocols performed outside hemodialysis centers[14]. Our meta-analysis demonstrates the benefits of intradialytic exercise and expands its results with a more thorough analysis of cardiopulmonary function in CKD patients[15-17]. VO2peak is the main evaluation parameter of cardiopulmonary function. It is considered the gold standard for evaluating cardiopulmonary fitness and directly assesses aerobic capacity. Using submaximal exercise protocols to assess cardiopulmonary function is unreliable, since they are limited by physiological mechanisms and methodological inaccuracies. The main determinants of VO2peak are genetic factors, age, sex, body composition and greater activation of the neuromuscular mechanism, which can be improved through physical training[9]. Moreover, VO2peak is inversely linked with cardiovascular risk and all-cause mortality[18]. The results of this review showed that intradialytic exercise three times a week for at least three months led to a significant increase in VO2peak, despite the high and significant heterogeneity of the included studies. The low cardiopulmonary capacity of hemodialysis patients has a number of causes, including anemia, muscular atrophy, cardiac dysfunction due to hypervolemia, metabolic disorders, reduced cardiac response to exercise and physical deconditioning[19]. The effects of exercise on aerobic capacity in end-stage renal disease are related to important cardiovascular outcomes, as well as to improved cardiac performance and output. Thus, the maximal cardiopulmonary stress test could be a useful approach for risk stratification in CKD patients, providing prognostic information and predicting survival[10,18]. In the stratified analysis according to training modality, intradialytic aerobic exercise alone did not significantly alter VO2peak values in the random effects model. This corroborates the results of Groussard et al. (2015), whose aerobic exercise group showed improvement only in the submaximal exercise test[12]. This finding shows that aerobic exercise alone may only benefit activities of daily living in these patients and not cardiopulmonary fitness. However, Sheng et al. (2014) found contrary results, i.e. that aerobic exercise alone can improve VO2peak[15]. Their review included studies by Van Vilsteren et al. (2005), Painter et al. (2002) and Koufaki et al. (2002), which were excluded from this meta-analysis due to methodological biases, such as obtaining VO2peak with a submaximal test[20] and altered drug regimens[21], as well as for allocating patients who underwent peritoneal dialysis and hemodialysis in the same group[22]. Moreover, in Vilsteren et al. (2005) only aerobic training occurred during dialysis; strength training was performed during the pre-hemodialysis period[20]. The meta-analysis of studies that combined intradialytic aerobic exercise and strength training revealed more relevant and favorable results regarding VO2peak improvement. The results were significant in both models (fixed and random effects). Gomes Neto et al. (2018), whose meta-analysis also included a stratified analysis according to training modality in a random effects model, found similar results to the present study, although they also included studies by Painter et al. (2002) and Van Vilsteren et al. (2005)[17,20,21]. Strength training helps improve the oxidative capacity of muscle due to increased oxygen use, which contributes to less muscle fatigue and, consequently, greater exercise tolerance[9,10,23]. Moreover, any exercise modality can improve nutrition and blood flow to the muscles, as well as increase circulation from small vessels to more central vessels, contributing to a greater clearance of blood metabolites during hemodialysis[24]. Our findings demonstrated that a combination of aerobic exercise and strength training can increase exercise tolerance time, since the meta-analysis included four studies that evaluated the duration of cardiopulmonary exercise testing and found significant results. The studies that used aerobic training alone prevented a similar analysis due to lack of data. However, Reboredo et al. (2011), who used aerobic training alone, found a significant increase in constant work-rate test time, which is considered as important as increased VO2peak itself[6]. Groussard et al. (2015) reported that greater increases in VO2peak are related to training duration, and more significant changes were found in studies with exercise protocols of at least six months[12]. The training duration of most studies included in the present meta-analysis was longer than six months, which corroborates this statement. The positive effects of intradialytic exercise on VO2peak were verified through the pulmonary ventilation values obtained during the maximum cardiopulmonary stress test. These results demonstrated the reduced ventilatory work of hemodialysis patients who exercised[25]. Pulmonary ventilation increases linearly with VO2peak and reflects the demand, in liters per minute, of the volume of air forced in and out of the lungs during the maximal cardiopulmonary stress test. Ventilatory demand is influenced by an individual’s degree of physical deconditioning[9]. Intradialytic exercise protocols are prescribed to improve the physical fitness of hemodialysis patients. Increased pulmonary ventilation is associated with cardiac performance, which influences the strength of the muscles involved in this mechanism, improving the respiratory system’s efficiency and, consequently, contributing to improved cardiopulmonary fitness[25]. As a study limitation, we point out the low or very low quality of evidence of the included RCTs according to the GRADE evaluation.

Conclusions

We can conclude that intradialytic exercise protocols can improve cardiopulmonary function, exercise tolerance and ventilatory efficiency in CKD patients, although a combination of aerobic and resistance training offers greater benefits. Supplementary information
  25 in total

Review 1.  ATS/ACCP Statement on cardiopulmonary exercise testing.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2003-01-15       Impact factor: 21.405

2.  Beneficial effects of an intradialytic cycling training program in patients with end-stage kidney disease.

Authors:  Carole Groussard; Myriam Rouchon-Isnard; Céline Coutard; Fanny Romain; Ludivine Malardé; Sophie Lemoine-Morel; Brice Martin; Bruno Pereira; Nathalie Boisseau
Journal:  Appl Physiol Nutr Metab       Date:  2015-05-08       Impact factor: 2.665

3.  The effects of a low-to-moderate intensity pre-conditioning exercise programme linked with exercise counselling for sedentary haemodialysis patients in The Netherlands: results of a randomized clinical trial.

Authors:  Marieke C B A van Vilsteren; Mathieu H G de Greef; Roel M Huisman
Journal:  Nephrol Dial Transplant       Date:  2004-11-02       Impact factor: 5.992

4.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  J Clin Epidemiol       Date:  2009-07-23       Impact factor: 6.437

Review 5.  Intradialytic exercise in hemodialysis patients: a systematic review and meta-analysis.

Authors:  Kaixiang Sheng; Ping Zhang; Lili Chen; Jun Cheng; Congcong Wu; Jianghua Chen
Journal:  Am J Nephrol       Date:  2014-12-09       Impact factor: 3.754

6.  Acute effects of intradialytic aerobic exercise on solute removal, blood gases and oxidative stress in patients with chronic kidney disease.

Authors:  Joseane Böhm; Mariane Borba Monteiro; Francini Porcher Andrade; Francisco Veríssimo Veronese; Fernando Saldanha Thomé
Journal:  J Bras Nefrol       Date:  2017-04-27

7.  Cardiorespiratory fitness and cardiovascular burden in chronic kidney disease.

Authors:  Erin J Howden; Kassia Weston; Rodel Leano; James E Sharman; Thomas H Marwick; Nicole M Isbel; Jeff S Coombes
Journal:  J Sci Med Sport       Date:  2014-07-18       Impact factor: 4.319

8.  Intradialytic exercise training modalities on physical functioning and health-related quality of life in patients undergoing maintenance hemodialysis: systematic review and meta-analysis.

Authors:  Mansueto Gomes Neto; Filipe Ferrari Ribeiro de Lacerda; Antonio Alberto Lopes; Bruno Prata Martinez; Micheli Bernardone Saquetto
Journal:  Clin Rehabil       Date:  2018-02-26       Impact factor: 3.477

9.  Effects of inspiratory muscle training on pulmonary functions and muscle strength in sedentary hemodialysis patients.

Authors:  Heba A Bahey El-Deen; Fahad Salam Alanazi; Khaled Takey Ahmed
Journal:  J Phys Ther Sci       Date:  2018-03-02

10.  Respiratory muscle impairment in dialysis patients: can minimal dose of exercise limit the damage? A Preliminary study in a sample of patients enrolled in the EXCITE trial.

Authors:  Luca Pomidori; Nicola Lamberti; Anna Maria Malagoni; Fabio Manfredini; Enrico Pozzato; Michele Felisatti; Luigi Catizone; Antonio Barillà; Alessandro Zuccalà; Giovanni Tripepi; Francesca Mallamaci; Carmine Zoccali; Annalisa Cogo
Journal:  J Nephrol       Date:  2016-06-16       Impact factor: 3.902

View more
  7 in total

1.  Clinical practice guideline exercise and lifestyle in chronic kidney disease.

Authors:  Luke A Baker; Daniel S March; Thomas J Wilkinson; Roseanne E Billany; Nicolette C Bishop; Ellen M Castle; Joseph Chilcot; Mark D Davies; Matthew P M Graham-Brown; Sharlene A Greenwood; Naushad A Junglee; Archontissa M Kanavaki; Courtney J Lightfoot; Jamie H Macdonald; Gabriella M K Rossetti; Alice C Smith; James O Burton
Journal:  BMC Nephrol       Date:  2022-02-22       Impact factor: 2.388

Review 2.  Exercise intolerance in kidney diseases: physiological contributors and therapeutic strategies.

Authors:  Danielle L Kirkman; Natalie Bohmke; Salvatore Carbone; Ryan S Garten; Paula Rodriguez-Miguelez; Robert L Franco; Jason M Kidd; Antonio Abbate
Journal:  Am J Physiol Renal Physiol       Date:  2020-12-07

3.  Effects of intradialytic exercise for advanced-age patients undergoing hemodialysis: A randomized controlled trial.

Authors:  Hiroki Yabe; Kenichi Kono; Tomoya Yamaguchi; Yumiko Ishikawa; Yoshiko Yamaguchi; Hisanori Azekura
Journal:  PLoS One       Date:  2021-10-22       Impact factor: 3.240

4.  The optimal exercise modality and intensity for hemodialysis patients incorporating Bayesian network meta-analysis and systematic review.

Authors:  Yangyang Song; Lei Chen; Meng Wang; Quan He; Jinhong Xue; Hongli Jiang
Journal:  Front Physiol       Date:  2022-09-19       Impact factor: 4.755

Review 5.  Therapeutic effects of exercise interventions for patients with chronic kidney disease: an umbrella review of systematic reviews and meta-analyses.

Authors:  Fan Zhang; Yan Bai; Xing Zhao; Liuyan Huang; Weiqiong Wang; Wenqin Zhou; Huachun Zhang
Journal:  BMJ Open       Date:  2022-09-19       Impact factor: 3.006

Review 6.  Intradialytic Nutrition and Hemodialysis Prescriptions: A Personalized Stepwise Approach.

Authors:  Giorgina Barbara Piccoli; Francoise Lippi; Antioco Fois; Lurlynis Gendrot; Louise Nielsen; Jerome Vigreux; Antoine Chatrenet; Claudia D'Alessandro; Gianfranca Cabiddu; Adamasco Cupisti
Journal:  Nutrients       Date:  2020-03-16       Impact factor: 5.717

7.  The role of physical activity and miRNAs in the vascular aging and cardiac health of dialysis patients.

Authors:  Miroslava Rabajdova; Ivana Spakova; Aurel Zelko; Jaroslav Rosenberger; Peter Kolarcik; Vladimira Sobolova; Daniel Pella; Maria Marekova; Andrea Madarasova Geckova
Journal:  Physiol Rep       Date:  2021-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.